LAMP1 and ovarian carcinoma: Similar results were achieved in other two studies, in which ALT-803 was found to enhance the function of NK cells against several ovarian cancer cell lines, multiple myeloma, and leukemia target cells with significant increases of CD107a, IFN-γ, and TNF-α expression.24,48